Pacific Pro Testing specializes in setting up workplace drug testing programs and would love to help you out. Please contact us with your needs and we will promptly reply with answers to your questions and solutions for your needs. We can be reached at info@pacificprotesting.com or (253) 245-9254.

Originally, the responsibility for establishing the policies for the Federal Workplace Drug Testing Program was given to the National Institute on Drug Abuse (NIDA). In 1993, HHS reorganized several administrations and the responsibility for the workplace program was given to the Division of Workplace Programs (DWP) within the Center for Substance Abuse Prevention (CSAP) in the Substance Abuse and Mental Health Services Administration (SAMHSA). Please remember that NIDA is no longer associated with the workplace drug testing program.

Please call DOT directly at 202-366-3784 or visit its website at www.dot/ost/dapc.

There is no established optimum percentage of random tests that will ensure the most effective deterrence and detection program. Logically, a very small percentage (e.g., 5 percent) may not be sufficient to deter or detect someone abusing an illicit substance, while a very high percentage (e.g., 95 percent) might be much more than is needed to maintain an effective program. The Department of Transportation permits the percentage of random tests to vary depending on the positive rate. In some cases, an industry is permitted to test at a 10 percent random rate while another industry is required to test at a 50 percent rate.

It is true that drugs can possibly be detected in hair for 3 to 6 months compared to several days for urine. However, this advantage does not necessarily apply in all circumstances of use and reasons for testing an individual.

We can screen for most any illicit drug.The list below is what is included in a ten-panel drug screen.In addition, we can test for alcohol and steroids.
Ten Panel Drug Screen:
Cocaine
Phencyclidine (PCP)
Opiates
Methamphetamine
Methadone
Amphetamine
Barbiturates
Benzodiazepines
Tricyclic Antidepressants

The time a drug is detectable in urine is dependent on a number of variables, such as metabolic rate, dose, how it was taken, and the cutoff concentration used by the laboratory to detect the drug.Below is a table listing the approximate time a drug is detectable.

Pacific Pro Testing can administer breath alcohol tests for an employer, which will detect the use/abuse of alcohol.  Testing Federal agency employees for alcohol use/abuse is not a part of the HHS Federal Workplace Drug Testing Program. However, the Department of Transportation does permit its regulated industry employers to test its employees for alcohol. Call DOT at 202-366-3784 or visit the DOT website at www.dot.gov/ost/dapc to access DOT regulations.

If your company uses Pacific Pro Testing as a collector, we can provide the services of an MRO.Additional information on physicians serving as MROs can be found at the following websites: www.asam.org, www.acoem.org, www.aamro.com
I am an employee (for example, truck driver, merchant mariner, pilot, etc) covered under the DOT regulations.

The current list of HHS-certified laboratories is published in the Federal Register during the first week of each month.

Call DWP at 240-276-2600 and a copy will be mailed or faxed to you.

The Center for Substance Abuse Treatment (CSAT) of the Substance Abuse and Mental Health Services Administration (SAMHSA), within the U.S. Department of Health and Human Services (HHS), promotes the quality and availability of community-based substance abuse treatment services for individuals and families who need them. CSAT works with States and community-based groups to improve and expand existing substance abuse treatment services under the Substance Abuse Prevention and Treatment Block Grant Program. CSAT also supports SAMHSA’s free treatment referral service to link people with the community-based substance abuse services they need. All treatment questions should be addressed to the Center for Substance Abuse Treatment. Visit the CSAT website at http://csat.samhsa.gov or call CSAT’s Division of Pharmacologic Therapies at 240-276-2700.